This review summarises two presentations delivered by Dr Vinay Vanguru and Dr Cathy Burton during an AbbVie educational seminar in May 2025, with commentary by Prof Eliza Hawkes. The presentations explore the latest advancements shaping the future of diffuse large B-cell lymphoma management, with a focus on the role of bispecifics.
Please login below to download this issue (PDF)